Skip to main content

Photochemotherapy of vascular cells with 8-methoxypsoralen and visible light: differential effects on endothelial and smooth muscle cells

Buy Article:

$51.00 plus tax (Refund Policy)



The long-term efficacy of percutaneous transluminal coronary angioplasty is limited by the restenosis which occurs in approximately 40% of patients, usually within 6 months of the procedure. Purpose:

The present study was designed to evaluate the effects of 8-methoxypsoralen (8-MOP) activated with visible light on the properties of bovine aortic smooth muscle cells (SMC) and endothelial cells (EC) in vitro. Methods:

Cells were seeded in polystyrene wells, allowed to attach over a 24-h period, incubated with 1, 20, or 50 µg/ml 8-MOP and then exposed to 12 J/cm2 visible light (447 nm). Cell counts were performed for up 14 days (n = 4–6 wells per time point), and each experiment was performed in triplicate. Cellular migration, morphology, and size were also analyzed. Results:

The lowest 8-MOP dose (1 µg/ml) had no significant effect on SMC proliferation, while the highest dose (50 µg/ml) induced cytostasis. An intermediate dose of 8-MOP (20 µg/ml) produced a transient and reversible inhibition of proliferation. There was no significant effect on proliferation of EC at lowest dose of 8-MOP (1 µg/ml). However, in contrast to the SMC experiments, a transient and reversible inhibition of EC proliferation was seen at both 20 and 50 µg/ml 8-MOP. Conclusions:

These experiments demonstrate that while 8-MOP photoactivated with 447 nm visible light can reversibly inhibit the proliferation of both SMC and EC in a dose-dependent fashion, SMC are more sensitive to the treatment than EC.

Keywords: 8-MOP; phototherapy; vascular cells

Document Type: Research Article


Affiliations: Department of Surgery (Vascular), Yale University School of Medicine, New Haven, CT 06510, USA

Publication date: October 1, 2002


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more